- LAVA Therapeutics N.V. (Nasdaq: LVTX) today announced initial clinical data from its ongoing Phase 1/2a study of LAVA-1207 in patients with therapy refractory metastatic castration resistant prostate cancer (mCRPC).
- Seelos recently released in vivo gene therapy data of SLS-004 utilizing CRISPR-dCas9 in Parkinson's disease demonstrating downregulation of alpha synuclein and recovery of tyrosine hydroxylase-positive (TH+)
The Company requests stockholders to vote in favor of the proposals at the February 28, 2023 special meeting and submit proxies in respect thereof
The Company received $50.0 million ($44.5
Ford President and Chief Executive Officer Jim Farley and Chief Financial Officer John Lawler will discuss the company's ambitious, customer-focused plan to grow and create value – and the double transformation
Centessa Pharmaceuticals plc (NASDAQ:CNTA), a clinical-stage pharmaceutical company that aims to discover and develop medicines that are transformational for patients, today announced that the Company will present
After the overwhelming success of last year's event, the Benzinga Cannabis Capital Conference is returning to Miami beach April 11-12, 2023 with events simultaneously taking place on two stages at Miami Beach’s historic Fontaineb
E3, the largest video game conference and trade show in the world, is facing a setback for its upcoming 2023 edition: Microsoft (NASDAQ: MSFT)'s Xbox, Sony (NYSE: SONY) and Ni